Can treatment with SSRIs increase the risk of suicide in some patients?
LEXAPRO is indicated for the treatment of major depression and prevention of relapse in adults. Adult and pediatric depressed patients can experience worsening of their depression and/or the emergence of suicidal ideation and behavior (suicidality), whether or not they are taking antidepressant medications. This risk may last until the depression goes away. Although no role for antidepressants in causing such behaviors has been established, healthcare professionals should observe their patients closely for clinical worsening and suicidality, especially at the beginning of a course of drug therapy, or at the time of dose changes, either increases or decreases. Important note: If you or someone you know has thoughts of suicide, seek professional help immediately through your healthcare provider, or call 411 to get the phone number for the nearest local suicide hotline.
Related Questions
- Are glucocorticoids a consistent risk factor for infections in rheumatoid arthritis patients under treatment with methotrexate and etanercept?
- Does low-dose and short-term glucocorticoids treatment increase the risk of osteoporosis in rheumatoid arthritis female patients?
- Do hypertension and diuretic treatment in pregnancy increase the risk of schizophrenia in offspring?
